1. bookVolumen 56 (2022): Edición 4 (October 2022)
Detalles de la revista
License
Formato
Revista
eISSN
1336-0329
Primera edición
30 Mar 2016
Calendario de la edición
4 veces al año
Idiomas
Inglés
Acceso abierto

The impact of type 2 diabetes duration on serum asymmetric dimethylarginine and C-reactive protein concentration in Bosnian patients

Publicado en línea: 20 Oct 2022
Volumen & Edición: Volumen 56 (2022) - Edición 4 (October 2022)
Páginas: 271 - 278
Detalles de la revista
License
Formato
Revista
eISSN
1336-0329
Primera edición
30 Mar 2016
Calendario de la edición
4 veces al año
Idiomas
Inglés

American Diabetes Association. Standards of medical care for patients with diabetes mellitus (Position Statement). Diabetes Care 28 (suppl 1), s4–s36, 2005.10.2337/diacare.28.suppl_1.S4 Search in Google Scholar

Baron AD, Brechtel G. Insulin differentially regulates systemic and skeletal muscle vascular resistance. Am J Physiol 265, E61–E67, 1993.10.1152/ajpendo.1993.265.1.E618338155 Search in Google Scholar

Bollenbach A, Schutte AE, Kruger R, Tsikas D. An ethnic comparison of arginine dimethylation and cardiometabolic factors in healthy black and white youth: The ASOS and African-PREDICT Studies. J Clin Med 9, 844, 2020.10.3390/jcm9030844714131732244968 Search in Google Scholar

Celik M, Cerrah S, Arabul M, Akalin A. Relation of asymmetric dimethylarginine levels to macrovascular disease and inflammation markers in type 2 diabetic patients. J Diabetes Res 2014, 139215, 2014.10.1155/2014/139215399688524804267 Search in Google Scholar

Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18, 499–502, 1972.10.1093/clinchem/18.6.499 Search in Google Scholar

Ganz T, Wainstein J, Gilad S, Limor R, Boaz M, Stern N. Serum asymmetric dimethylarginine and arginine levels predict microvascular and macrovascular complications in type 2 diabetes mellitus. Diabetes Metab Res Rev 33, 2017.10.1002/dmrr.283627393712 Search in Google Scholar

Ghule A, Kamble TK, Talwar D, Kumar S, Acharya S, Wanjari A, Gaidhane SA, Agrawal S. Association of serum high sensitivity C-reactive protein with pre-diabetes in rural population: A two-year cross-sectional study. Cureus 13, e19088, 2021.10.7759/cureus.19088862671034868746 Search in Google Scholar

Groos S, Kretschmann J, Macare C, Weber A, Hagen B. Quality assurance report 2016 disease-management-programmes in North Rhine, 2017. Available at https://www.kvno.de/downloads/quali/qualbe_dmp16.pdf. Accessed 23 Jun 2022. Search in Google Scholar

Hisalkar PJ, Shekhar PB, Bidwe SE, Kamble CG, Nemade ST, Powar JD, Patne A. Asymmetrical dimethylarginine (ADMA), an endothelial dysfunctional biomarker for type 2 diabetes mellitus, the meta analysis. Ind J Bas Appl Med Res 6, 496–506, 2017. Search in Google Scholar

Hsu CP, Hsu PF, Chung MY, Lin SJ, Lu TM. Asymmetric dimethylarginine and long-term adverse cardiovascular events in patients with type 2 diabetes: relation with the glycemic control. Cardiovasc Diabetol 13, 156, 2014.10.1186/s12933-014-0156-1426214425467091 Search in Google Scholar

Jawalekar SL, Karnik A, Bhutey A. Risk of cardiovascular diseases in diabetes mellitus and serum concentration of asymmetrical dimethylarginine. Biochem Res Int 2013, 189430, 2013.10.1155/2013/189430380427724187621 Search in Google Scholar

Kanmani S, Kwon M, Shin MK, Kim MK. Association of C-reactive protein with risk of developing type 2 diabetes mellitus, and role of obesity and hypertension: A large population-based Korean cohort study. Sci Rep 9, 4573, 2019.10.1038/s41598-019-40987-8641810230872696 Search in Google Scholar

Kelley-Hedgepeth A, Lloyd-Jones DM, Colvin A, Matthews KA, Johnston J, Sowers MR, Sternfeld B, Pasternak RC, Chae CU; SWAN Investigators. Ethnic differences in C-reactive protein concentrations. Clin Chem 54, 1027–1037, 2008.10.1373/clinchem.2007.09899618403563 Search in Google Scholar

Krzyzanowska K, Mittermayer F, Krugluger W, Schnack C, Hofer M, Wolzt M, Schernthaner G. Asymmetric dimethylarginine is associated with macrovascular disease and total homocysteine in patients with type 2 diabetes. Atherosclerosis 189, 236–240, 2006.10.1016/j.atherosclerosis.2005.12.00716414052 Search in Google Scholar

Kuniss N, Freyer M, Muller N, Kielstein V, Muller UA. Expectations and fear of diabetes-related long-term complications in people with type 2 diabetes at primary care level. Acta Diabetol 56, 33–38, 2019.10.1007/s00592-018-1217-930159745 Search in Google Scholar

Liu C, Feng X, Li Q, Wang Y, Li Q, Hua M. Adiponectin, TNF-α and inflammatory cytokines and risk of type 2 diabetes: A systematic review and meta-analysis. Cytokine 86, 100–109, 2016.10.1016/j.cyto.2016.06.02827498215 Search in Google Scholar

Matthews KA, Sowers MF, Derby CA, Stein E, Miracle-McMahill H, Crawford SL, Pasternak RC. Ethnic differences in cardiovascular risk factor burden among middle-aged women: Study of Women’s Health Across the Nation (SWAN). Am Heart J 149, 1066–1073, 2005.10.1016/j.ahj.2004.08.02715976790 Search in Google Scholar

Nazmi A, Victora CG. Socioeconomic and racial/ethnic differentials of C-reactive protein levels: a systematic review of population-based studies. BMC Public Health 7, 212, 2007.10.1186/1471-2458-7-212201871917705867 Search in Google Scholar

Pan A, Wang Y, Yuan JM, Koh WP. High-sensitive C-reactive protein and risk of incident type 2 diabetes: a case-control study nested within the Singapore Chinese Health Study. BMC Endocr Disord 17, 8, 2017.10.1186/s12902-017-0159-5529977728178951 Search in Google Scholar

Paiva H, Lehtimaki T, Laakso J, Ruokonen I, Rantalaiho V, Wirta O, Pasternack A, Laaksonen R. Plasma concentrations of asymmetric-dimethyl-arginine in type 2 diabetes associate with glycemic control and glomerular filtration rate but not with risk factors of vasculopathy. Metabolism 52, 303–307, 2003.10.1053/meta.2003.5004812647267 Search in Google Scholar

Rajendran P, Rengarajan T, Thangavel J, Nishigaki Y, Sakthisekaran D, Sethi G, Nishigaki I. The vascular endothelium and human diseases. Int J Biol Sci 9, 1057–1069, 2013.10.7150/ijbs.7502383111924250251 Search in Google Scholar

Sciacqua A, Grillo N, Quero M, Sesti G, Perticone F. Asymmetric dimethylarginine plasma levels and endothelial function in newly diagnosed type 2 diabetic patients. Int J Mol Sci 13, 13804–13815, 2012.10.3390/ijms131113804350955123203035 Search in Google Scholar

Schutte AE, Schutte R, Huisman HW, van Rooyen JM, Fourie CM, Malan L, Malan NT, Schwedhelm E, Strimbeanu S, Anderssohn M, Boger RH. Dimethylarginines: their vascular and metabolic roles in Africans and Caucasians. Eur J Endocrinol 162, 525–533, 2010.10.1530/EJE-09-086519996198 Search in Google Scholar

Shi Y, Vanhoutte PM. Macro- and microvascular endothelial dysfunction in diabetes. J Diabetes 9, 434–449, 2017.10.1111/1753-0407.1252128044409 Search in Google Scholar

Sydow K, Fortmann SP, Fair JM, Varady A, Hlatky MA, Go AS, Iribarren C, Tsao PS; ADVANCE Investigators. Distribution of asymmetric dimethylarginine among 980 healthy, older adults of different ethnicities. Clin Chem 56, 111–120, 2010.10.1373/clinchem.2009.13620019892843 Search in Google Scholar

Tsikas D, Bollenbach A, Hanff E, Kayacelebi AA. Asymmetric dimethylarginine (ADMA), symmetric dimethylargi-nine (SDMA) and homoarginine (hArg): the ADMA, SDMA and hArg paradoxes. Cardiovasc Diabetol 17, 1, 2018.10.1186/s12933-017-0656-x575349229301528 Search in Google Scholar

Wang X, Bao W, Liu J, Ouyang YY, Wang D, Rong S, Xiao X, Shan ZL, Zhang Y, Yao P, Liu LG. Inflammatory markers and risk of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care 36, 166–175, 2013.10.2337/dc12-0702352624923264288 Search in Google Scholar

Wang Y, Wang QJ. The prevalence of prehypertension and hypertension among US adults according to the new joint national committee guidelines: New challenges of the old problem. Arch Intern Med 164, 2126–2134, 2004.10.1001/archinte.164.19.212615505126 Search in Google Scholar

Wieczor R, Wieczor AM, Kulwas A, Rosc D. ADMA (asymmetric dimethylarginine) and angiogenic potential in patients with type 2 diabetes and prediabetes. Exp Biol Med 246, 153–162, 2021.10.1177/1535370220959738787112132957808 Search in Google Scholar

Xiong Y, Lei M, Fu S, Fu Y. Effect of diabetic duration on serum concentrations of endogenous inhibitor of nitric oxide synthase in patients and rats with diabetes. Life Sci 77, 149–159, 2005.10.1016/j.lfs.2004.10.06215862600 Search in Google Scholar

Zaciragic A, Hasanefendic B, Avdagic N, Lepara O, Babic N, Huskic J, Mulabegovic N. Gender comparison of serum asymmetric dimethylarhinine and C-reactive protein concentration in patients with diabetes mellitus type 2. Medical Journal 20, 85–90, 2014. Search in Google Scholar

Artículos recomendados de Trend MD

Planifique su conferencia remota con Sciendo